{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:46:51Z","timestamp":1782708411471,"version":"3.54.5"},"reference-count":35,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Cutaneous T-cell lymphoma is a chronic disease with a highly heterogeneous and unpre-dictable clinical course, and the impact on psychological resilience is still unknown. The primary aim was to investigate psychological resilience in cutaneous T-cell lymphoma patients over time and to relate it to dermatology-related quality of life (QoL) metrics. Psychological investigations were evaluated in 45 patients with mycosis fungoides included in the BIO-MUSE study. Psychological resilience was assessed using the Connor\u2013Davidson Resilience Scale (CD-RISC), and dermatology-associated QoL was assessed with the Dermatology Life Quality Index (DLQI) and numeric rating scales for itch and sleep disorders. The resilience of the mycosis fungoides patients was further compared to a Swedish general population cohort comprising more than 2,500 individuals. This study demonstrates that mycosis fungoides patients in the BIO-MUSE cohort, where 39 of 45 cases had early-stage disease, exhibit a high and stable resilience over 1 year of the disease. The CD-RISC score is higher than in a Swedish general population cohort and in a subgroup of that cohort with psoriasis or eczema. Furthermore, the DLQI was consistently low, indicating a higher QoL in the BIO-MUSE cohort than in published data for similar patient populations.<\/jats:p>","DOI":"10.2340\/actadv.v106.adv-2025-0211","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:38:29Z","timestamp":1782707909000},"source":"Crossref","is-referenced-by-count":0,"title":["Psychological Resilience and Quality of Life in Mycosis Fungoides Patients: A BIO-MUSE Study"],"prefix":"10.2340","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0522-9827","authenticated-orcid":false,"given":"Angelica","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Velickovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Belfrage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Drott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Johnsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"160711","doi-asserted-by":"crossref","unstructured":"Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood 2019; 133: 1703\u20131714.","DOI":"10.1182\/blood-2018-11-881268"},{"key":"160712","doi-asserted-by":"crossref","unstructured":"Kempf W, Zimmermann AK, Mitteldorf C. Cutaneous lymphomas-An update 2019. Hematol Oncol 2019; 37: 43\u201347.","DOI":"10.1002\/hon.2584"},{"key":"160713","doi-asserted-by":"crossref","unstructured":"Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, et al. Survival outcomes and prognostic factors in mycosis fungoides\/S\u00e9zary syndrome: Validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and Treatment of Cancer staging proposal. J Clin Oncol 2010; 28: 4730\u20134739.","DOI":"10.1200\/JCO.2009.27.7665"},{"key":"160714","doi-asserted-by":"crossref","unstructured":"Mourad A, Gniadecki R. Overall survival in mycosis fungoides: A systematic review and meta-analysis. J Invest Dermatol 2020; 140: 495\u2013497.","DOI":"10.1016\/j.jid.2019.07.712"},{"key":"160715","doi-asserted-by":"crossref","unstructured":"Brunner PM, Jonak C, Knobler R. Recent advances in understanding and managing cutaneous T-cell lymphomas. F1000Res 2020; 9: 9.","DOI":"10.12688\/f1000research.21922.1"},{"key":"160716","doi-asserted-by":"crossref","unstructured":"Brazel D, Larocca C, Shinohara MM. Assessing health-related quality of life in mycosis fungoides and S\u00e9zary syndrome: Unmet needs. Cancers (Basel) 2024; 16: 2757.","DOI":"10.3390\/cancers16152757"},{"key":"160717","doi-asserted-by":"crossref","unstructured":"Molloy K, Jonak C, Woei-A-Jin FJSH, Guenova E, Busschots AM, Bervoets A, et al. Characteristics associated with significantly worse quality of life in mycosis fungoides\/S\u00e9zary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermatol 2020; 182: 770\u2013779.","DOI":"10.1111\/bjd.18089"},{"key":"160718","doi-asserted-by":"crossref","unstructured":"Damiani G, Tacastacas JD, Wuerz T, Miller L, Fastenau P, Bailey C, et al. Cognition\/psychological burden and resilience in cutaneous T-cell lymphoma and psoriasis patients: Real-life data and implications for the treatment. Biomed Res Int 2022; 2022: 8802469.","DOI":"10.1155\/2022\/8802469"},{"key":"160719","doi-asserted-by":"crossref","unstructured":"Ottevanger R, van Beugen S, Evers AWM, Willemze R, Vermeer MH, Quint KD. Quality of life in patients with mycosis fungoides and S\u00e9zary syndrome: A systematic review of the literature. J Eur Acad Dermatol Venereol 2021; 35: 2377\u20132387.","DOI":"10.1111\/jdv.17570"},{"key":"160720","doi-asserted-by":"crossref","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--A simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210\u2013216.","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"160721","doi-asserted-by":"crossref","unstructured":"Chen CC, Sun XF, Liu ZY, Jiao MR, Wei WH, Hu YL. The relationship between resilience and quality of life in advanced cancer survivors: Multiple mediating effects of social support and spirituality. Front Public Health 2023; 11: 11.","DOI":"10.3389\/fpubh.2023.1207097"},{"key":"160722","doi-asserted-by":"crossref","unstructured":"Musich S, Wang SHS, Schaeffer JA, Kraemer S, Wicker E, Yeh CS. The association of increasing resilience with positive health outcomes among older adults. Geriatr Nurs 2022; 44: 97\u2013104.","DOI":"10.1016\/j.gerinurse.2022.01.007"},{"key":"160723","doi-asserted-by":"crossref","unstructured":"Connor KM, Davidson JRT. Development of a new resilience scale: The Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety 2003; 18: 76\u201382.","DOI":"10.1002\/da.10113"},{"key":"160724","doi-asserted-by":"crossref","unstructured":"Sharif-Nia H, S\u00e1nchez-Teruel D, Sivarajan Froelicher E, Hejazi S, Hosseini L, Khoshnavay Fomani F, et al. Connor-Davidson Resilience Scale: A systematic review psychometrics properties using the COSMIN. Ann Med Surg (Lond) 2024; 86: 2976\u20132991.","DOI":"10.1097\/MS9.0000000000001968"},{"key":"160725","doi-asserted-by":"crossref","unstructured":"Velickovic K, Rahm Hallberg I, Axelsson U, Borrebaeck CAK, Ryd\u00e9n L, Johnsson P, et al. Psychometric properties of the Connor-Davidson Resilience Scale (CD-RISC) in a non-clinical population in Sweden. Health Qual Life Outcomes 2020; 18: 132.","DOI":"10.1186\/s12955-020-01383-3"},{"key":"160726","doi-asserted-by":"crossref","unstructured":"Belfrage E, Ek S, Johansson \u00c5, Brauner H, Sonesson A, Drott K. Predictive and prognostic biomarkers in patients with mycosis fungoides and S\u00e9zary syndrome (BIO-MUSE): Protocol for a translational study. JMIR Res Protoc 2024; 13: e55723.","DOI":"10.2196\/55723"},{"key":"160727","unstructured":"S\u00f6der KSSF. Region Sk\u00e5ne: BIG3. 2022."},{"key":"160728","doi-asserted-by":"crossref","unstructured":"Till\u00e9 Y. Sampling algorithms. In: Lovric M, editor. International Encyclopedia of Statistical Science. 2 edn. Vol Berlin Heidelberg: Springer; 2025.","DOI":"10.1007\/978-3-662-69359-9_545"},{"key":"160729","unstructured":"Folkh\u00e4lsomyndigheten. Vuxnas bruk av tobaks och nikotinprodukter. 2024."},{"key":"160730","unstructured":"Dancey CPaR J. Statistics without maths for psychology. 4 edn. Harlow: Pearson Education; 2007."},{"key":"160731","unstructured":"Team RC. R: A Language and Environment for Statistical Computing. 4.2.2 edn. R Foundation for Statistical Computing; 2022."},{"key":"160732","unstructured":"Corp I. IBM SPSS Statistics for Windows. Armonk, NY: IBM Corp; 2023."},{"key":"160733","doi-asserted-by":"crossref","unstructured":"Mohlin \u00c5, Bendahl PO, Hegardt C, Richter C, Hallberg IR, Ryd\u00e9n L. Psychological resilience and health-related quality of life in 418 Swedish women with primary breast cancer: Results from a prospective longitudinal study. Cancers (Basel) 2021; 13: 13.","DOI":"10.3390\/cancers13092233"},{"key":"160734","doi-asserted-by":"crossref","unstructured":"Axelsson U, Ryd\u00e9n L, Johnsson P, Ed\u00e9n P, M\u00e5nsson J, Hallberg IR, et al. A multicenter study investigating the molecular fingerprint of psychological resilience in breast cancer patients: Study protocol of the SCAN-B resilience study. BMC Cancer 2018; 18: 789.","DOI":"10.1186\/s12885-018-4669-y"},{"key":"160735","doi-asserted-by":"crossref","unstructured":"Veli\u010dkovi\u0107 K, Borrebaeck CAK, Bendahl PO, Hegardt C, Johnsson P, Richter C, et al. One-year recovery from breast cancer: Importance of tumor and treatment-related factors, resilience, and sociodemographic factors for health-related quality of life. Front Oncol 2022; 12: 891850.","DOI":"10.3389\/fonc.2022.891850"},{"key":"160736","doi-asserted-by":"crossref","unstructured":"Quaglino P, Prince HM, Cowan R, Vermeer M, Papadavid E, Bagot M, et al. Treatment of early-stage mycosis fungoides: Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. Br J Dermatol 2021; 184: 722\u2013730.","DOI":"10.1111\/bjd.19252"},{"key":"160737","doi-asserted-by":"crossref","unstructured":"Shen ZY, Zhang L, Shi SJ, Ruan CH, Dan L, Li CY. The relationship between uncertainty and fear of disease progression among newly diagnosed cancer patients: The mediating role of intolerance of uncertainty. BMC Psychiatry 2024; 24: 24.","DOI":"10.1186\/s12888-024-06201-4"},{"key":"160738","doi-asserted-by":"crossref","unstructured":"Nenonen J, Winther AH, Jonsson P, Ivert LU, Brauner H. Identification of subgroups of early-stage mycosis fungoides patients with increased itch and impaired quality of life. Front Oncol 2025; 15: 1524353.","DOI":"10.3389\/fonc.2025.1524353"},{"key":"160739","doi-asserted-by":"crossref","unstructured":"Hub D, Drott K, Belfrage E, Sonesson A. Quality of life in a Swedish cohort of patients with mycosis fungoides. Acta Derm Venereol 2026; 106: 0364.","DOI":"10.2340\/actadv.v106.adv-2026-0364"},{"key":"160740","doi-asserted-by":"crossref","unstructured":"Jennings T, Duffy R, Gochoco A, Knoblauch K, Shi W, Alpdogan SO, et al. Valchlor maintenance therapy for patients with mycosis fungoides who received low dose total skin electron beam treatment. Chin Clin Oncol 2019; 8: 13.","DOI":"10.21037\/cco.2018.10.01"},{"key":"160741","doi-asserted-by":"crossref","unstructured":"Steinke S, Zeidler C, Riepe C, Bruland P, Soto-Rey I, Storck M, et al. Humanistic burden of chronic pruritus in patients with inflammatory dermatoses: Results of the European Academy of Dermatology and Venereology Network on Assessment of Severity and Burden of Pruritus (PruNet) cross-sectional trial. J Am Acad Dermatol 2018; 79: 457\u2013463.","DOI":"10.1016\/j.jaad.2018.04.044"},{"key":"160742","doi-asserted-by":"crossref","unstructured":"Ottevanger R, van Beugen S, Evers AWM, Willemze R, Vermeer MH, Quint KD. Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator. JAAD Int 2022; 9: 57\u201364.","DOI":"10.1016\/j.jdin.2022.07.007"},{"key":"160743","doi-asserted-by":"crossref","unstructured":"Roggo A, W\u00fcest Y, Dummer R, Ramelyte E. Pruritus is an indicator for quality of life in cutaneous T-cell lymphoma. J Dermatol 2025; 52: 1404\u20131410.","DOI":"10.1111\/1346-8138.17847"},{"key":"160744","doi-asserted-by":"crossref","unstructured":"Halioua B, Charles B, Taieb C, Richard MA. Dispositional optimism and resilience in patients with psoriasis in France: A cross\u2010sectional study. Acad Dermatol Venereol 2023; 37: E1468\u2013E1470.","DOI":"10.1111\/jdv.19367"},{"key":"160745","doi-asserted-by":"crossref","unstructured":"Halioua B, Patras de Campaigno C, Merhand S, Charles B, Bru MF, Legrand C, et al. Resilience of patients with skin diseases in France: A cross\u2010sectional study. Acad Dermatol Venereol 2023; 37: E163\u2013E165.","DOI":"10.1111\/jdv.18681"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46392\/54536","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46392\/54537","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46392\/54538","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46392\/54536","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T04:38:57Z","timestamp":1782707937000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/46392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":35,"URL":"https:\/\/doi.org\/10.2340\/actadv.v106.adv-2025-0211","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}